Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma von Gan, Hui K, Reardon, David A, Lassman, Andrew B, Merrell, Ryan, van den Bent, Martin, Butowski, Nicholas, Lwin, Zarnie, Wheeler, Helen, Fichtel, Lisa, Scott, Andrew M, Gomez, Erica J, Fischer, JuDee, Mandich, Helen, Xiong, Hao, Lee, Ho-Jin, Munasinghe, Wijith P, Roberts-Rapp, Lisa A, Ansell, Peter J, Holen, Kyle D, Kumthekar, Priya

Volltext

Comparative Bioavailability of Two Formulations of Biopharmaceutical Classification System (BCS) Class IV Drugs: A Case Study of Lopinavir/Ritonavir von Saeed, Ahmed M., Schmidt, Jeffery M., Munasinghe, Wijith P., Vallabh, Bhadrish K., Jarvis, Michael F., Morris, John B., Mostafa, Nael M.

Volltext

Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies von Gray, Heidi J., Bell-McGuinn, Katherine, Fleming, Gini F., Cristea, Mihaela, Xiong, Hao, Sullivan, Danielle, Luo, Yan, McKee, Mark D., Munasinghe, Wijith, Martin, Lainie P.

Volltext

Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma von Costa, Luciano J., Stadtmauer, Edward Allen, Morgan, Gareth John, Monohan, Gregory P., Kovacsovics, Tibor, Burwick, Nicholas, Jakubowiak, Andrzej J., Mobasher, Mehrdad, Freise, Kevin, Ross, Jeremy A., Pesko, John Carl, Munasinghe, Wijith, Cordero, Jaclyn, Morris, Lura, Maciag, Paulo Cesar, Bueno, Orlando, Kumar, Shaji

Volltext

Phase I study of ABT-414 mono- or combination therapy with temozolomide (TMZ) in recurrent glioblastoma (GBM) von Gan, Hui K., Papadopoulos, Kyriakos P., Fichtel, Lisa, Lassman, Andrew B., Merrell, Ryan, Van Den Bent, Martin J., Kumthekar, Priya, Scott, Andrew M., Pedersen, Michelle, Gomez, Erica J., Fischer, Judee S., Ames, William, Xiong, Hao, Lee, Ho-Jin, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle D., Lai, Rose, Reardon, David A.

Volltext

ATNT-01ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR):... von Gan, Hui K., Kumthekar, Priya, Lassman, Andrew B., Merrell, Ryan, van den Bent, Martin, Papadopoulos, Kyriakos P., Scott, Andrew M., Gomez, Erica, Fischer, JuDee, Mandich, Helen, Xiong, Hao, Lee, Ho-Jin, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle, Lai, Rose, Reardon, David A.

Volltext